Nanomaterials in Ultrasound Theragnostics

The use of ultrasound technology holds the potential to diagnose and treat multiple diseases at the same time. Over the past few decades, nanomaterials have transformed the field of nanomedicine, with a critical role in the diagnosis, treatment, and surveillance of various diseases. Ultrasonic theragnostic platforms have proven to be the most effective of all the methods used in nanomedicine. By improving the clarity of ultrasound images, nanoparticles (NPs) can make organs and their anomalies easier to see. This chapter seeks to clarify the function of nanomaterial-based nanomedicine in the medical domain by examining its various forms, workings and future directions. Nanomaterials can be employed in therapeutic applications to improve drug penetration in addition to drug delivery. In nanomedicine, ultrasound theragnostics is a potential method. Nanomaterials, such as metallic nanoparticles, metal oxide nanoparticles, semiconductor nanoparticles, polymeric nanoparticles, liposomes, dendrimers, and carbon-based nanomaterials are engineered to possess specific properties such as enhanced acoustic impedance, biocompatibility, and targeting specific tissues or cells. The fundamental mechanisms of ultrasound theragnostic involve ultrasound imaging and therapeutic ultrasound, which leads to proper diagnosis and treatment, significantly in neurological disorders, cardiovascular diseases, and cancer. Nanomaterials can enhance the contrast and resolution of ultrasound images, making it easier to identify pathological changes. They can also respond to ultrasound waves, releasing therapeutic agents or generating heat to destroy diseased tissues. However, challenges include biocompatibility, targeting efficiency, regulatory approval, and cost. Ensuring biocompatibility and minimizing toxicity are crucial for clinical application. Improving targeting efficiency is essential for effective diagnosis and treatment. Regulatory approval is complex and requires extensive preclinical and clinical studies, whereas cost and scalability are also significant factors. Despite challenges, ongoing research and development hold promise for overcoming these obstacles. The future of nanomaterials in ultrasound theragnostic lies in personalized medicine, multimodal theragnostic platforms, smart nanomaterials, and successful clinical translation.